clinical trial · NCT04973826
Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.
Pfizer·phase1·completed·n = 12
HealthyAztreonam-Avibactam
brief summary
A Phase 1, single center, single arm, open-label study to assess the PK, safety and tolerability of Aztreonam-Avibactam after single and repeated IV infusion of doses in healthy Chinese participants.
started
Aug 20, 2021
primary completion
Sep 27, 2021
completion
Sep 27, 2021
last updated
Jul 28, 2023
official title
A PHASE I, SINGLE CENTER, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AZTREONAM-AVIBACTAM ADMINISTERED AS SINGLE AND REPEATED INTRAVENOUS DOSES IN HEALTHY CHINESE PARTICIPANTS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol